← 홈

CGT · HER2+ 유방암

33개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 33개
CGTBiologicMerck Sharp & Dohme LLCPhase 3

Recombinant Interferon Alfa-2b (Recombinant Interferon Alfa-2b)

Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8 · HER2

#HER2#CGT#Phase3#인기#세포유전치료+5
임상시험 63상태 ACTIVE
CGTBiologicGamma Medica-IdeasPhase 2

tamoxifen citrate (tamoxifen citrate)

Male Breast Cancer; Stage II Breast Cancer · Breast Cancer

#BreastCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 13%임상시험 60상태 ACTIVE
CGTBiologicAcrotech Biopharma Inc.Vedotin, and BelinostatPhase 1

Belinostat (Belinostat)

Breast Adenocarcinoma; Metastatic Breast Carcinoma · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase1#세포유전치료#CAR-T+5
효능 ORR 25%임상시험 45상태 DISCONTINUED
CGTBiologicOncolytics BiotechPhase 2

Pelareorep (Pelareorep)

Breast Cancer Metastatic · Breast Cancer Metastatic

#BreastCancerMetastatic#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 27%임상시험 35상태 RECRUITING
CGTBiologicstaleElvira UmyarovaPhase 1

Universal Donor Expanded TGF-beta-imprinted NK Cells (Universal Donor Expanded TGF-beta-imprinted NK Cells)

Recurrent Multiple Myeloma; Refractory Multiple Myeloma · HER2

#HER2#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 4상태 ACTIVE
CGTBiologicstaleChristian HinrichsPhase 1

KK-LC-1 TCR-T cells (KK-LC-1 TCR-T cells)

Gastric Cancer; Breast Cancer · Gastric Cancer

#GastricCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
CGTBiologicstaleGuangdong ProCapZoom Bioscience…Phase 1

SZ011 CAR-NK (SZ011 CAR-NK)

Advanced Triple Negative Breast Cancer · Advanced Triple Negative Breast Cancer

#AdvancedTripleNegativeBreastCanc#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 2상태 RECRUITING
CGTBiologicstaleGuangzhou Anjie Biomedical Tech…Phase 2

AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells (AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells)

Advanced Breast Cancer; Breast Neoplasm Malignant Female · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleCytoMed Therapeutics Pte LtdPhase 1

Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell (Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell)

Colorectal Cancer; Triple Negative Breast Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleZhi YangPhase 2

Anti-HER2 CAR-T (Anti-HER2 CAR-T)

Breast Cancer; Ovarian Cancer · HER2

#HER2#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 DISCONTINUED
CGTBiologicstaleUTC Therapeutics Inc.Preclinical

Anti-HER2 CAR-T cells (Anti-HER2 CAR-T cells)

HER2-positive Advanced Malignant Solid Tumors · HER2

#HER2#CGT#Preclinical#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of Southern Californ…Phase 1

Anti-HLA-A2/NY-ESO-1 TCR-transduced Autologous T Lymphocytes (Anti-HLA-A2/NY-ESO-1 TCR-transduced Autologous T Lymphocytes)

Triple Negative Breast Cancer · Triple Negative Breast Cancer

#TripleNegativeBreastCancer#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

Anti-MAGE-A3 human leukocyte antigen serotype within HLA-A A serotype group (HLA-A* 01, Anti-MAGE-A3 human leukocyte antigen serotype within HLA-A A serotype group, Anti-MAGE-A3 human leukocyte antigen serotype within HLA-A A serotype group (HLA-A* 01)-restricted T-cell receptor (TCR))

Breast Cancer; Cervical Cancer · Breast Cancer

#BreastCancer#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 0%임상시험 1상태 DISCONTINUED
CGTBiologicstaleEssen BiotechPhase 2

CD146/HER2 CAR-T cells (CD146/HER2 CAR-T cells)

Sarcoma; Sarcoma, Kaposi · HER2

#HER2#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 2

EB-DT-CAR-NK (Dual-target CAR-NK cells, Dual-target CAR-NK cells (EB-DT-CAR-NK))

Breast Cancer (Locally Advanced or Metastatic); HER2-positive Breast Cancer · HER2

#HER2#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleSichuan UniversityPhase 1

Dual-targeting HER2 and PD-L1 CAR-T cells (Dual-targeting HER2 and PD-L1 CAR-T cells)

Peritoneal Carcinoma Metastatic; Pleural Effusion, Malignant · HER2

#HER2#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING
CGTBiologicstaleSecond Affiliated Hospital of G…Phase 1

EGFR/B7H3 CAR-T (EGFR/B7H3 CAR-T)

EGFR/ B7H3-positive Advanced Lung Cancer; EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 2

EGFR/HER2 Dual-Target CAR-NK Cells (EGFR/HER2 Dual-Target CAR-NK Cells)

Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma; Biomarker-positive EGFR/HER2- Expressing HNSCC · HER2

#HER2#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING
CGTBiologicstaleSichuan UniversityPhase 1

EpCAM CAR-T cells (EpCAM CAR-T cells)

Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M); Breast Cancer Recurrent · Malignant Neoplasm of Nasopharynx TNM St

#MalignantNeoplasmofNasopharynxTN#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleFuda Cancer Hospital, GuangzhouPhase 2

HER-2-targeting CAR T Cells infusion (HER-2-targeting CAR T Cells infusion)

Breast Cancer · Breast Cancer

#BreastCancer#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 DISCONTINUED

1 / 2 페이지

← 이전다음 →